Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis

Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis

Implementation of higher dose (HD) thromboprophylaxis has been considered in patients infected with coronavirus disease 2019 (COVID-19). Our aim was to compare HD to standard dose (SD) thromboprophylaxis in COVID-19 patients. The protocol is registered on PROSPERO (CRD42021284808). We searched for r...

Full description

Bibliographic Details
Main Authors: Emőke Henrietta Kovács, Krisztián Tánczos, László Szabó, Caner Turan, Fanni Dembrovszky, Klementina Ocskay, Bo-Young Lee, Péter Hegyi, Zsolt Molnár
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biomedicines
Subjects:
COVID-19
anticoagulation
thromboinflamation
disease progression
Online Access:https://www.mdpi.com/2227-9059/10/9/2194

Internet

https://www.mdpi.com/2227-9059/10/9/2194

Similar Items